Jailendra Singh
Stock Analyst at Truist Securities
(0.99)
# 3,872
Out of 5,017 analysts
185
Total ratings
29.9%
Success rate
-21.54%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Buy | $35 → $36 | $22.24 | +61.87% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $54.73 | -32.40% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $186.05 | +25.77% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $527.40 | -17.33% | 5 | Jul 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $209 → $235 | $203.77 | +15.33% | 16 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $36.17 | +41.02% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $20.43 | +32.16% | 10 | Jul 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $14 → $16 | $7.68 | +108.33% | 7 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $67.50 | -9.63% | 9 | Jul 17, 2025 | |
| HNGE Hinge Health | Initiates: Buy | $48 | $50.40 | -4.76% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $8.25 | +9.09% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $24.14 | +15.99% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $4.16 | +32.21% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $5.83 | +28.64% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $29.32 | +56.89% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $286.09 | -26.60% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.06 | +39.17% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.89 | +629.44% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.34 | +199.54% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $4.59 | +836.82% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.99 | +702.68% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.90 | +110.53% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $154.31 | -62.41% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $4.40 | +922.73% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $769.49 | -56.72% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.63 | +242.21% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $27.99 | - | 3 | Jan 15, 2021 |
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $22.24
Upside: +61.87%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $54.73
Upside: -32.40%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $186.05
Upside: +25.77%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $527.40
Upside: -17.33%
IQVIA Holdings
Jul 23, 2025
Maintains: Buy
Price Target: $209 → $235
Current: $203.77
Upside: +15.33%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $36.17
Upside: +41.02%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $20.43
Upside: +32.16%
Evolent Health
Jul 17, 2025
Maintains: Buy
Price Target: $14 → $16
Current: $7.68
Upside: +108.33%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $67.50
Upside: -9.63%
Hinge Health
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $50.40
Upside: -4.76%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $8.25
Upside: +9.09%
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $24.14
Upside: +15.99%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.16
Upside: +32.21%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $5.83
Upside: +28.64%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $29.32
Upside: +56.89%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $286.09
Upside: -26.60%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.06
Upside: +39.17%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.89
Upside: +629.44%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.34
Upside: +199.54%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $4.59
Upside: +836.82%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.99
Upside: +702.68%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.90
Upside: +110.53%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $154.31
Upside: -62.41%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $4.40
Upside: +922.73%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $769.49
Upside: -56.72%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.63
Upside: +242.21%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $27.99
Upside: -